EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C20H18FNO4 |
| Net Charge | 0 |
| Average Mass | 355.365 |
| Monoisotopic Mass | 355.12199 |
| SMILES | COc1cccc(-c2ccc(NC(=O)C3=C(C(=O)O)CCC3)c(F)c2)c1 |
| InChI | InChI=1S/C20H18FNO4/c1-26-14-5-2-4-12(10-14)13-8-9-18(17(21)11-13)22-19(23)15-6-3-7-16(15)20(24)25/h2,4-5,8-11H,3,6-7H2,1H3,(H,22,23)(H,24,25) |
| InChIKey | XPRDUGXOWVXZLL-UHFFFAOYSA-N |
| Roles Classification |
|---|
| Biological Roles: | immunosuppressive agent An agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response. antiviral agent A substance that destroys or inhibits replication of viruses. |
| Applications: | immunosuppressive agent An agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response. antirheumatic drug A drug used to treat rheumatoid arthritis. anti-inflammatory agent Any compound that has anti-inflammatory effects. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| vidofludimus (CHEBI:748718) has role anti-inflammatory agent (CHEBI:67079) |
| vidofludimus (CHEBI:748718) has role antirheumatic drug (CHEBI:35842) |
| vidofludimus (CHEBI:748718) has role antiviral agent (CHEBI:22587) |
| vidofludimus (CHEBI:748718) has role immunosuppressive agent (CHEBI:35705) |
| vidofludimus (CHEBI:748718) is a anilide (CHEBI:13248) |
| INN | Source |
|---|---|
| vidofludimus | WHO MedNet |
| Synonyms | Source |
|---|---|
| 4SC-101 | ChEMBL |
| IMU-838 | ChEMBL |
| NSC-717824 | ChEMBL |
| SC-12267 | ChEMBL |
| SC12267 | ChEMBL |
| Citations |
|---|